| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.TRANON.2015.04.003 |
| P8608 | Fatcat ID | release_2nitk4kxdjhdjo5dtbtdmehyiq |
| P932 | PMC publication ID | 4487794 |
| P698 | PubMed publication ID | 26055180 |
| P5875 | ResearchGate publication ID | 277784869 |
| P2093 | author name string | Jeon-Hor Chen | |
| Wei-Ching Lin | |||
| P2860 | cites work | Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T | Q88208192 |
| Cancer statistics, 2013 | Q27860762 | ||
| Diffusion-weighted MR imaging of intracerebral hemorrhage | Q28344090 | ||
| Diffusion measurements in intracranial hematomas: implications for MR imaging of acute stroke | Q30608816 | ||
| Diffusion-weighted MR imaging of the brain | Q30619236 | ||
| Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy | Q30834007 | ||
| Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma | Q30839472 | ||
| Diffusion-weighted MR imaging for characterizing musculoskeletal lesions. | Q30850135 | ||
| Hypointensity on diffusion-weighted MRI of the brain related to T2 shortening and susceptibility effects | Q30884417 | ||
| Magnetic resonance imaging of bone marrow in oncology, Part 1. | Q31112183 | ||
| Diffusion-weighted MRI in the body: applications and challenges in oncology | Q31113294 | ||
| Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues | Q31144011 | ||
| Diffusion-weighted imaging of bone marrow | Q33448640 | ||
| Whole-body MRI for the staging and follow-up of patients with metastasis | Q33449129 | ||
| Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer | Q33464875 | ||
| Diffusion and perfusion imaging of bone marrow | Q33551725 | ||
| Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review | Q33818245 | ||
| Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis | Q33913747 | ||
| Bladder cancer staging | Q34015298 | ||
| Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies | Q34021978 | ||
| ErbB2 and NFκB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer | Q34079347 | ||
| Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity | Q34155874 | ||
| Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer | Q34194464 | ||
| Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience. | Q34324399 | ||
| Role of apparent diffusion coefficients with diffusion-weighted magnetic resonance imaging in differentiating between benign and malignant bone tumors | Q34694899 | ||
| Bony metastases: assessing response to therapy with whole-body diffusion MRI. | Q35697593 | ||
| The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions | Q36324987 | ||
| Abdominal MRI at 3.0 T: the basics revisited | Q36484380 | ||
| Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI | Q36653176 | ||
| Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. | Q37073257 | ||
| Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen | Q37354645 | ||
| Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade | Q37427184 | ||
| Bladder cancer in 2010: how far have we come? | Q37766697 | ||
| Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature | Q37945936 | ||
| Whole-body diffusion-weighted MR imaging in cancer: current status and research directions | Q37957827 | ||
| Urinary bladder cancer: role of MR imaging | Q37993016 | ||
| Genitourinary applications of diffusion-weighted MR imaging in the pelvis | Q38003969 | ||
| Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls | Q38028905 | ||
| Agreement and reproducibility of apparent diffusion coefficient measurements of dual-b-value and multi-b-value diffusion-weighted magnetic resonance imaging at 1.5 Tesla in phantom and in soft tissues of the abdomen. | Q38074295 | ||
| Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. | Q38112846 | ||
| MR imaging of urinary bladder cancer for T-staging: a review and a pictorial essay of diffusion-weighted imaging | Q38165147 | ||
| p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer | Q38448806 | ||
| Comparison of cystoscopy with diffusion-weighted magnetic resonance images used in the diagnosis and follow-up of patients with bladder tumors. | Q39809348 | ||
| The Urachus: its Anatomy, Histology and Development | Q42078960 | ||
| Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. | Q43407465 | ||
| Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer | Q43735245 | ||
| High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results | Q44432319 | ||
| Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy | Q44710572 | ||
| Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI. | Q44803663 | ||
| Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study | Q44818814 | ||
| Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. | Q45967681 | ||
| Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria | Q46409781 | ||
| Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. | Q46644825 | ||
| Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. | Q46748189 | ||
| Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. | Q50498618 | ||
| Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer. | Q50516951 | ||
| Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. | Q51081679 | ||
| Histogram analysis of apparent diffusion coefficient at 3.0 T in urinary bladder lesions: correlation with pathologic findings. | Q51085106 | ||
| Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection? | Q51341726 | ||
| Bladder cancer: utility of MRI in detection of occult muscle-invasive disease. | Q52625811 | ||
| Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. | Q53072594 | ||
| Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection. | Q53094158 | ||
| Diffusion-weighted MR imaging in diagnosis of superficial and invasive urinary bladder carcinoma: a preliminary prospective study. | Q55129417 | ||
| Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases | Q61917185 | ||
| Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer | Q63966352 | ||
| MR imaging features of transitional cell carcinoma of the urinary bladder | Q73013818 | ||
| MR imaging features of non-transitional cell carcinoma of the urinary bladder with pathologic correlation | Q73013820 | ||
| Carcinosarcoma of the urinary bladder: dynamic contrast-enhanced MR imaging with clinical and pathologic correlation | Q73556910 | ||
| Histopathological analysis of a bladder cancer stalk observed on MRI | Q73731823 | ||
| In re: characterization of benign and metastatic vertebral compression fractures with quantitative diffusion MR imaging | Q73806108 | ||
| Relationship between bone marrow cellularity and apparent diffusion coefficient | Q73820550 | ||
| Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy | Q74216421 | ||
| HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications | Q78516471 | ||
| Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? | Q78953814 | ||
| Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results | Q79978488 | ||
| Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences | Q80473085 | ||
| A comparison between clinical and pathologic staging in patients with bladder cancer | Q81306147 | ||
| Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy | Q81356885 | ||
| Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma | Q81583728 | ||
| Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor | Q81596099 | ||
| Evaluation of diffusion-weighted imaging for the differential diagnosis of poorly contrast-enhanced and T2-prolonged bone masses: Initial experience | Q82538827 | ||
| Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients | Q83187080 | ||
| Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? | Q83691115 | ||
| Tumour pathology of the bladder: the role of MRI | Q83781872 | ||
| Diffusion-weighted MRI of urinary bladder and prostate cancers | Q84046725 | ||
| Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness | Q84395729 | ||
| The diagnostic value of diffusion-weighted magnetic resonance imaging in soft tissue abscesses | Q84549953 | ||
| Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation | Q84577525 | ||
| Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer | Q84904285 | ||
| Role of diffusion MRI and apparent diffusion coefficient measurement in the diagnosis, staging and pathological classification of bladder tumors | Q84968100 | ||
| Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer | Q85297319 | ||
| Conventional and diffusion-weighted MRI features in diagnosis of metastatic lymphadenopathy in bladder cancer | Q85859085 | ||
| Utility of diffusion-weighted MRI in the diagnosis of bladder carcinoma | Q87190446 | ||
| Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness | Q87531013 | ||
| Value of normalized apparent diffusion coefficient for estimating histological grade of vesical urothelial carcinoma | Q87869574 | ||
| Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness | Q88149718 | ||
| P433 | issue | 3 | |
| P921 | main subject | bladder cancer | Q504775 |
| diffusion-weighted magnetic resonance imaging | Q899360 | ||
| P304 | page(s) | 217-230 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Translational Oncology | Q26839583 |
| P1476 | title | Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer | |
| P478 | volume | 8 |
| Q94554002 | 18F-FDG positron emission tomography and diffusion-weighted magnetic resonance imaging for response evaluation of nanoparticle-mediated photothermal therapy |
| Q93228454 | A glance at imaging bladder cancer |
| Q49487185 | Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI. |
| Q57545693 | C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial) |
| Q52719758 | Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. |
| Q58802895 | Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer |
| Q53805308 | Diffusion weighted magnetic resonance imaging in bladder cancer, is it time to replace biopsy? |
| Q92910476 | Diffusion-weighted magnetic resonance imaging in bladder cancer: comparison of readout-segmented and single-shot EPI techniques |
| Q59130946 | Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review |
| Q91607199 | Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer |
| Q38786175 | Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems. |
| Q92734214 | Organ preservation in bladder cancer: an opportunity for truly personalized treatment |
| Q54962224 | Pitfalls of diffusion-weighted imaging of the female pelvis. |
| Q40330581 | Pure Lymphoepithelioma-Like Carcinoma Originating from the Urinary Bladder. |
| Q47124309 | Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging |
| Q52897587 | Utility of early dynamic and delayed post-diuretic 18F-FDG PET/CT SUVmax in predicting tumour grade and T-stage of urinary bladder carcinoma: results from a prospective single centre study. |
Search more.